Addition Of A Sleeve To The Etanercept Autoinjector (Enbrel® MyClic®) Improves Ease Of Use In Patients With Rheumatoid Arthritis

Naceur Rekaya,1 Alexandra Pickersgill,1 Louisa Harvey2 1Pfizer R&D Ltd, Device Centre of Excellence, Cambridge, UK; 2Harvey Medical Consulting Ltd, Cambridge, UKCorrespondence: Naceur RekayaPfizer R&D Ltd, Device Centre of Excellence, Granta Park, Great Abington, Cambridge CB21 6GP,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Rekaya N, Pickersgill A, Harvey L
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2019
Materias:
Acceso en línea:https://doaj.org/article/c7b382f701cd40eba7d38564c41b2577
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c7b382f701cd40eba7d38564c41b2577
record_format dspace
spelling oai:doaj.org-article:c7b382f701cd40eba7d38564c41b25772021-12-02T03:24:47ZAddition Of A Sleeve To The Etanercept Autoinjector (Enbrel® MyClic®) Improves Ease Of Use In Patients With Rheumatoid Arthritis1179-1470https://doaj.org/article/c7b382f701cd40eba7d38564c41b25772019-10-01T00:00:00Zhttps://www.dovepress.com/addition-of-a-sleeve-to-the-etanercept-autoinjector-enbrelreg-myclicre-peer-reviewed-article-MDERhttps://doaj.org/toc/1179-1470Naceur Rekaya,1 Alexandra Pickersgill,1 Louisa Harvey2 1Pfizer R&D Ltd, Device Centre of Excellence, Cambridge, UK; 2Harvey Medical Consulting Ltd, Cambridge, UKCorrespondence: Naceur RekayaPfizer R&D Ltd, Device Centre of Excellence, Granta Park, Great Abington, Cambridge CB21 6GP, UKTel +44 1304 616 161Email naceur.rekaya@pfizer.comPurpose: A novel device (sleeve) has been developed that attaches to compatible autoinjectors and is designed to improve the patient experience, particularly for those with limited manual dexterity. This study was designed to explore whether user experience is improved when using the Enbrel® MyClic® autoinjector in conjunction with the sleeve. The Enbrel MyClic autoinjector contains etanercept (Enbrel®), a biologic drug that patients self-administer subcutaneously for the treatment of rheumatoid arthritis (RA).Patients and methods: Twenty-four adult patients (16 female) with RA and varying degrees of manual dexterity impairment took part in this user study. Written informed consent was supplied by each patient prior to performing the study. They each performed two simulated injections into skin pads, one with the Enbrel MyClic alone and the other with the Enbrel MyClic + sleeve. Following the simulated injections, participants answered questions about their experience of using the sleeve and rated the following on a scale of 1 (poor experience) to 7 (optimal experience): overall use; ease of preparation; ease of administration; ease of learning to use; look, feel and size of the device; overall experience.Results: Participants rated the Enbrel MyClic + sleeve more highly than the Enbrel MyClic alone for overall use, ease of administration, feel, size and overall experience. Participants with severe dexterity impairment (n = 12) were more likely to rate these features as better with the sleeve in place than those with mild dexterity impairment (n = 10). Three-quarters of participants said they would request the sleeve if it became available and all said that they would recommend it to others. The main benefits cited by participants were better grip and a better feeling of control.Conclusion: Addition of the sleeve improved patients’ experience of using the Enbrel MyClic. The benefits of the sleeve outweighed any inconvenience associated with the additional steps needed to prepare the device.Keywords: human factors, usability, user studyRekaya NPickersgill AHarvey LDove Medical PressarticleHuman factorsusabilityuser studyMedical technologyR855-855.5ENMedical Devices: Evidence and Research, Vol Volume 12, Pp 443-450 (2019)
institution DOAJ
collection DOAJ
language EN
topic Human factors
usability
user study
Medical technology
R855-855.5
spellingShingle Human factors
usability
user study
Medical technology
R855-855.5
Rekaya N
Pickersgill A
Harvey L
Addition Of A Sleeve To The Etanercept Autoinjector (Enbrel® MyClic®) Improves Ease Of Use In Patients With Rheumatoid Arthritis
description Naceur Rekaya,1 Alexandra Pickersgill,1 Louisa Harvey2 1Pfizer R&D Ltd, Device Centre of Excellence, Cambridge, UK; 2Harvey Medical Consulting Ltd, Cambridge, UKCorrespondence: Naceur RekayaPfizer R&D Ltd, Device Centre of Excellence, Granta Park, Great Abington, Cambridge CB21 6GP, UKTel +44 1304 616 161Email naceur.rekaya@pfizer.comPurpose: A novel device (sleeve) has been developed that attaches to compatible autoinjectors and is designed to improve the patient experience, particularly for those with limited manual dexterity. This study was designed to explore whether user experience is improved when using the Enbrel® MyClic® autoinjector in conjunction with the sleeve. The Enbrel MyClic autoinjector contains etanercept (Enbrel®), a biologic drug that patients self-administer subcutaneously for the treatment of rheumatoid arthritis (RA).Patients and methods: Twenty-four adult patients (16 female) with RA and varying degrees of manual dexterity impairment took part in this user study. Written informed consent was supplied by each patient prior to performing the study. They each performed two simulated injections into skin pads, one with the Enbrel MyClic alone and the other with the Enbrel MyClic + sleeve. Following the simulated injections, participants answered questions about their experience of using the sleeve and rated the following on a scale of 1 (poor experience) to 7 (optimal experience): overall use; ease of preparation; ease of administration; ease of learning to use; look, feel and size of the device; overall experience.Results: Participants rated the Enbrel MyClic + sleeve more highly than the Enbrel MyClic alone for overall use, ease of administration, feel, size and overall experience. Participants with severe dexterity impairment (n = 12) were more likely to rate these features as better with the sleeve in place than those with mild dexterity impairment (n = 10). Three-quarters of participants said they would request the sleeve if it became available and all said that they would recommend it to others. The main benefits cited by participants were better grip and a better feeling of control.Conclusion: Addition of the sleeve improved patients’ experience of using the Enbrel MyClic. The benefits of the sleeve outweighed any inconvenience associated with the additional steps needed to prepare the device.Keywords: human factors, usability, user study
format article
author Rekaya N
Pickersgill A
Harvey L
author_facet Rekaya N
Pickersgill A
Harvey L
author_sort Rekaya N
title Addition Of A Sleeve To The Etanercept Autoinjector (Enbrel® MyClic®) Improves Ease Of Use In Patients With Rheumatoid Arthritis
title_short Addition Of A Sleeve To The Etanercept Autoinjector (Enbrel® MyClic®) Improves Ease Of Use In Patients With Rheumatoid Arthritis
title_full Addition Of A Sleeve To The Etanercept Autoinjector (Enbrel® MyClic®) Improves Ease Of Use In Patients With Rheumatoid Arthritis
title_fullStr Addition Of A Sleeve To The Etanercept Autoinjector (Enbrel® MyClic®) Improves Ease Of Use In Patients With Rheumatoid Arthritis
title_full_unstemmed Addition Of A Sleeve To The Etanercept Autoinjector (Enbrel® MyClic®) Improves Ease Of Use In Patients With Rheumatoid Arthritis
title_sort addition of a sleeve to the etanercept autoinjector (enbrel® myclic®) improves ease of use in patients with rheumatoid arthritis
publisher Dove Medical Press
publishDate 2019
url https://doaj.org/article/c7b382f701cd40eba7d38564c41b2577
work_keys_str_mv AT rekayan additionofasleevetotheetanerceptautoinjectorenbrelregmyclicregimproveseaseofuseinpatientswithrheumatoidarthritis
AT pickersgilla additionofasleevetotheetanerceptautoinjectorenbrelregmyclicregimproveseaseofuseinpatientswithrheumatoidarthritis
AT harveyl additionofasleevetotheetanerceptautoinjectorenbrelregmyclicregimproveseaseofuseinpatientswithrheumatoidarthritis
_version_ 1718401819825143808